These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33338804)

  • 1. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
    Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
    Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
    Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
    Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
    Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
    Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
    Li K; Zhang H; Qiu J; Lin Y; Liang J; Xiao X; Fu L; Wang F; Cai J; Tan Y; Zhu W; Yin W; Lu B; Xing F; Tang L; Yan M; Mai J; Li Y; Chen W; Qiu P; Su X; Gao G; Tai PW; Hu J; Yan G
    Mol Ther; 2016 Feb; 24(1):156-65. PubMed ID: 26373347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity.
    Garofalo M; Iovine B; Kuryk L; Capasso C; Hirvinen M; Vitale A; Yliperttula M; Bevilacqua MA; Cerullo V
    Mol Cancer Ther; 2016 Apr; 15(4):651-60. PubMed ID: 26861248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
    Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
    Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
    Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
    Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.
    Machitani M; Sakurai F; Wakabayashi K; Tachibana M; Fujiwara T; Mizuguchi H
    Mol Cancer Ther; 2017 Jan; 16(1):251-259. PubMed ID: 27760834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC.
    Zhang J; Liu Y; Tan J; Zhang Y; Wong CW; Lin Z; Liu X; Sander M; Yang X; Liang L; Song D; Dan J; Zhou Y; Cai J; Lin Y; Liang J; Hu J; Yan G; Zhu W
    Oncogene; 2021 Jul; 40(29):4783-4795. PubMed ID: 34155344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
    Lin Y; Zhang H; Liang J; Li K; Zhu W; Fu L; Wang F; Zheng X; Shi H; Wu S; Xiao X; Chen L; Tang L; Yan M; Yang X; Tan Y; Qiu P; Huang Y; Yin W; Su X; Hu H; Hu J; Yan G
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4504-12. PubMed ID: 25288727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
    Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
    Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
    Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers.
    Fehl DJ; Ahmed M
    Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
    Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
    J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells.
    Dan J; Nie L; Jia X; Xu C; Cai J; Lin Y; Hu J; Zhu W; Li Y; Chen D; Liu Y; Hu C; Yan G; Liang J; Zhang Q
    Virol Sin; 2021 Aug; 36(4):655-666. PubMed ID: 33481190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to Oncolytic Virotherapy.
    Engeland CE; Bell JC
    Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.